|
|
Inhaler Choice Matters in COPD: The Impact of Peak...
Monday, May 2111:30 AM - 12:15 PM
|
|
|
|
|
Looking to the future of COPD treatment: New evide...
Monday, May 211:15 PM - 2:00 PM
|
|
|
|
|
Nucala▼(Mepolizumab): Treating Severe Eosinophilic...
Tuesday, May 2211:30 AM - 12:15 PM
|
|
|
|
|
A Proven Long-Acting Muscarinic Antagonist for the...
Sunday, May 2011:30 AM - 12:00 PM
|
|
|
|
|
The First and Only Nebulized LAMA for COPD
Monday, May 211:15 PM - 2:00 PM
|
|
|
|
|
Why Long-Acting Dual Bronchodilation Should Be Use...
Tuesday, May 2211:30 AM - 12:15 PM
|
|
|
|
|
COPD Treatments, Exacerbations, and Relationship t...
Sunday, May 201:30 PM - 2:00 PM
|
|
|
|
|
FASENRA™ (benralizumab) Subcutaneous Injection 30 ...
Sunday, May 2011:30 AM - 12:15 PM
|
|
|
|
|
The Evolving Science of Asthma
Sunday, May 201:15 PM - 2:00 PM
|
|
|
|
|
Fundamentals of IPF: Navigating the Patient Journe...
Sunday, May 2011:30 AM - 12:15 PM
|
|
|
|
|
COPD and Treatment with Triple Therapy
Sunday, May 201:15 PM - 2:00 PM
|
|
|
|
|
What Do You Consider When Patients with COPD Class...
Tuesday, May 2211:30 AM - 12:00 PM
|
|
|
|
|
New Evidence in Treating Severe Eosinophilic Asthm...
Monday, May 2111:30 AM - 12:15 PM
|
|
|
|
|
Uncontrolled Asthma: Connecting Type 2 Inflammatio...
Tuesday, May 221:15 PM - 2:00 PM
|
|
|
|
|
The Salford Lung Study: Innovation in Asthma Resea...
Tuesday, May 221:15 PM - 2:00 PM
|
|
|
|
|
Cost-Effectiveness of Home Oxygen Therapy-Home Mec...
Monday, May 2112:30 PM - 1:00 PM
|
|
|
|
|
Lower Dose, Shorter Duration Therapy: OPTALYSE PE...
Monday, May 2111:30 AM - 12:00 PM
|
|
|
|
|
New evidence in COPD: is there consensus for clini...
Sunday, May 2012:30 PM - 1:00 PM
|
|
|
|
|
The importance of extrafine triple therapy in the ...
Tuesday, May 221:30 PM - 2:00 PM
|
|
|
Home
Inbox
Search